{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:24:54Z","timestamp":1782447894614,"version":"3.54.5"},"update-to":[{"DOI":"10.1371\/journal.ppat.1007262","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000}}],"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T00:00:00Z","timestamp":1535068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","award":["Internal Funding"],"award-info":[{"award-number":["Internal Funding"]}],"id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007262","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T17:36:51Z","timestamp":1535132211000},"page":"e1007262","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains"],"prefix":"10.1371","volume":"14","author":[{"given":"Jeehyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Klenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":true,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,8,24]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"e1005554","DOI":"10.1371\/journal.ppat.1005554","article-title":"Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins","volume":"12","author":"S Fuentes","year":"2016","journal-title":"PLoS Pathog"},{"issue":"25","key":"ref2","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"CB Hall","year":"2001","journal-title":"N Engl J Med"},{"issue":"9725","key":"ref3","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"H Nair","year":"2010","journal-title":"Lancet"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00006454-200207000-00005","article-title":"Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999","volume":"21","author":"S Leader","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/INF.0b013e31822e68e6","article-title":"Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997\u20132006","volume":"31","author":"LJ Stockman","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"ref6","first-page":"543","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"WP Glezen","year":"1986","journal-title":"Am J Dis Child"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM196207122670204","article-title":"Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease","volume":"267","author":"KM Johnson","year":"1962","journal-title":"N Engl J Med"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1128\/CMR.18.3.541-555.2005","article-title":"Immune responses and disease enhancement during respiratory syncytial virus infection","volume":"18","author":"PJ Openshaw","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"Pt 10","key":"ref9","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1099\/0022-1317-66-10-2111","article-title":"Two distinct subtypes of human respiratory syncytial virus","volume":"66","author":"MA Mufson","year":"1985","journal-title":"J Gen Virol"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1128\/JVI.69.5.2918-2925.1995","article-title":"Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein","volume":"69","author":"PA Cane","year":"1995","journal-title":"J Virol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"e51439","DOI":"10.1371\/journal.pone.0051439","article-title":"Genetic variability among complete human respiratory syncytial virus subgroup A genomes: bridging molecular evolutionary dynamics and epidemiology","volume":"7","author":"L Tan","year":"2012","journal-title":"PLoS One"},{"issue":"1\u20132","key":"ref12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"PL Collins","year":"2011","journal-title":"Virus Res"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/infdis\/jis570","article-title":"Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya","volume":"206","author":"CN Agoti","year":"2012","journal-title":"J Infect Dis"},{"issue":"11","key":"ref14","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/infdis\/jix489","article-title":"Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection","volume":"216","author":"C Capella","year":"2017","journal-title":"J Infect Dis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.vaccine.2016.11.044","article-title":"Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines","volume":"35","author":"S Fuentes","year":"2017","journal-title":"Vaccine"},{"issue":"16","key":"ref16","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1128\/JVI.00133-15","article-title":"Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels","volume":"89","author":"S Fuentes","year":"2015","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"42428","DOI":"10.1038\/srep42428","article-title":"Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model","volume":"7","author":"S Fuentes","year":"2017","journal-title":"Sci Rep"},{"issue":"37","key":"ref18","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1016\/j.vaccine.2013.05.088","article-title":"Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection","volume":"31","author":"S Fuentes","year":"2013","journal-title":"Vaccine"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/600108","article-title":"Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB\/c mice","volume":"200","author":"LM Haynes","year":"2009","journal-title":"J Infect Dis"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02357-16","article-title":"Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells","volume":"91","author":"B Cortjens","year":"2017","journal-title":"J Virol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.62.11.4232-4238.1988","article-title":"Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies","volume":"62","author":"LJ Anderson","year":"1988","journal-title":"J Virol"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/90675","article-title":"CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein","volume":"2","author":"RA Tripp","year":"2001","journal-title":"Nat Immunol"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"e1005318","DOI":"10.1371\/journal.ppat.1005318","article-title":"Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures","volume":"11","author":"SM Johnson","year":"2015","journal-title":"PLoS Pathog"},{"issue":"9","key":"ref24","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1099\/vir.0.000218","article-title":"CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells","volume":"96","author":"T Chirkova","year":"2015","journal-title":"J Gen Virol"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"e0130517","DOI":"10.1371\/journal.pone.0130517","article-title":"CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner","volume":"10","author":"KI Jeong","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"ref26","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.0901373","article-title":"Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients","volume":"183","author":"EJ Collarini","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.vaccine.2016.11.054","article-title":"Animal models of respiratory syncytial virus infection","volume":"35","author":"G. Taylor","year":"2017","journal-title":"Vaccine"},{"issue":"21","key":"ref28","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aar3534","article-title":"Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies","volume":"3","author":"SO Fedechkin","year":"2018","journal-title":"Sci Immunol"},{"issue":"3","key":"ref29","doi-asserted-by":"crossref","first-page":"e1006935","DOI":"10.1371\/journal.ppat.1006935","article-title":"Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies","volume":"14","author":"HG Jones","year":"2018","journal-title":"PLoS Pathog"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01302-17","article-title":"Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem","volume":"92","author":"RA Tripp","year":"2018","journal-title":"J Virol"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02059-16","article-title":"Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective","volume":"91","author":"S Boyoglu-Barnum","year":"2017","journal-title":"J Virol"},{"issue":"10","key":"ref32","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1084\/jem.188.10.1967","article-title":"Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus","volume":"188","author":"PW Tebbey","year":"1998","journal-title":"J Exp Med"},{"issue":"11","key":"ref33","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1084\/jem.187.11.1921","article-title":"Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia","volume":"187","author":"TE Sparer","year":"1998","journal-title":"J Exp Med"},{"issue":"9","key":"ref34","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/JVI.64.9.4232-4241.1990","article-title":"Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins","volume":"64","author":"JA Nicholas","year":"1990","journal-title":"J Virol"},{"issue":"Pt 8","key":"ref35","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1099\/vir.0.80131-0","article-title":"Human CD8(+) T cell responses against five newly identified respiratory syncytial virus-derived epitopes","volume":"85","author":"J Heidema","year":"2004","journal-title":"J Gen Virol"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/infdis\/175.2.342","article-title":"Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus","volume":"175","author":"DC Powers","year":"1997","journal-title":"J Infect Dis"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0264-410X(03)00570-X","article-title":"The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B","volume":"22","author":"UF Power","year":"2003","journal-title":"Vaccine"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1007262","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T07:07:55Z","timestamp":1604819275000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007262"}},"subtitle":[],"editor":[{"given":"Ralph A.","family":"Tripp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,8,24]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007262","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1007262","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,24]]}}}